05.05.14 -- FDA Publishes Final Guidance On Orphan mAB Sameness

By Erin Yeh and Qinghai Zhao , Joseph Bordas-Nagy , Ping Feng , TEVA Biopharmaceuticals Biosimilar, a term synonymous to "follow-on biologic," requires very stringent and high standards of comparability with the original biologic drug that is being replicated.

http://ift.tt/1ihZbIE